The PE Ratio as of November 2024 (TTM) for Oncolytics Biotech Inc. (ONCY) is -3.67

According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.67. This represents a change of -18.44% compared to the average of -4.50 of the last 4 quarters.

Oncolytics Biotech Inc. (ONCY) Historical PE Ratio (quarterly & annually)

How has ONCY PE Ratio performed in the past?

The mean historical PE Ratio of Oncolytics Biotech Inc. over the last ten years is -3.88. The current -3.67 PE Ratio has changed 9.37% with respect to the historical average. Over the past ten years (40 quarters), ONCY's PE Ratio was at its highest in in the March 2020 quarter at 43.53. The PE Ratio was at its lowest in in the March 2021 quarter at -9.24.

Oncolytics Biotech Inc. (ONCY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Oncolytics Biotech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oncolytics Biotech Inc. (ONCY) Average PE Ratio

How has ONCY PE Ratio performed in the past?

The current PE Ratio of Oncolytics Biotech Inc. (ONCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oncolytics Biotech Inc. (ONCY) PE Ratio vs. Peers

How is ONCY’s PE Ratio compared to its peers?

Oncolytics Biotech Inc.’s PE Ratio is less than scPharmaceuticals Inc. (-1.95), less than Milestone Pharmaceuticals Inc. (-2.85), greater than Seres Therapeutics, Inc. (-4.61), less than aTyr Pharma, Inc. (-2.33), greater than DiaMedica Therapeutics Inc. (-9.26), less than Inhibikase Therapeutics, Inc. (-1.05), less than X4 Pharmaceuticals, Inc. (0), greater than Galera Therapeutics, Inc. (-4.05), less than Terns Pharmaceuticals, Inc. (-0.07), greater than Day One Biopharmaceuticals, Inc. (-5.12), greater than HOOKIPA Pharma Inc. (-15.73), less than CureVac N.V. (-0.62), less than Reata Pharmaceuticals, Inc. (5.18), greater than Krystal Biotech, Inc. (-20.07), less than Vir Biotechnology, Inc. (104.40), less than Propanc Biopharma, Inc. (-1.82), less than null (-0.09),

Build a custom stock screener for Oncolytics Biotech Inc. (ONCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncolytics Biotech Inc. (ONCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.